Aptevo Therapeutics Inc expected to post a loss of $6.01 a share - Earnings Preview
Aptevo Therapeutics Inc <APVO.OQ> expected to post a loss of $6.01 a share - Earnings Preview
Aptevo Therapeutics Inc APVO.OQ APVO.O is expected to show no change in quarterly revenue when it reports results on August 10 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Aptevo Therapeutics Inc is for a loss of $6.01 per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Aptevo Therapeutics Inc is $25.50, about 526.5% above its last closing price of $4.07
This summary was machine generated August 7 at 15:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary